Advanced search

Filters

Capitalization

Sector

Select all

Add a keyword

Announcement Date

Since

Until

27 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NeoGenomics, Inc. Announces Resignation of Rachel Stahler from Board of Directors	23-06-29	CI
Organon : Presentation Opens a new window	23-06-13	PU
Cognizant Teams Up with Organon to Speed Delivery of Pharmaceutical Products and Improve Women's Healthcare	22-07-21	PR
NEOGENOMICS INC : Submission of Matters to a Vote of Security Holders (form 8-K)	22-06-03	AQ
Organon : Separation and Distribution (Form 8-K)	21-06-03	PU
Organon & Co. Announces Executive Changes	21-06-03	CI
Merck & Co., Inc. completed the Spin-Off of Organon & Co..	21-06-01	CI
NEOGENOMICS INC : Submission of Matters to a Vote of Security Holders (form 8-K)	21-06-01	AQ
Transcript : NeoGenomics, Inc. - Shareholder/Analyst Call	21-05-27
Neogenomics, Inc. Elects Rachel A. Stahler as a Member of the Board of Directors	20-06-03	CI
NEOGENOMICS INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)	20-06-03	AQ
Transcript : NeoGenomics, Inc. - Shareholder/Analyst Call	20-05-28
Merck : Announces Appointment of Organon and Co. Chief Financial Officer and Chief Information Officer	20-05-19	AQ
Merck Announces Management Changes	20-05-18	CI
Merck : CORRECTING and REPLACING Merck Announces Appointment of Organon & Co. Chief Financial Officer and Chief Information Officer	20-05-18	BU
Merck & Co., Inc. agreed to Spin-Off Women’s Health, Trusted Legacy Brands and Biosimilars Products of Merck & Co., Inc.	20-02-04	CI
Syneos Health Helps Establish New Industry Standards Group to Improve Clinical Trial Collaboration and Execution	18-03-27	GL
Align Clinical CRO: Leading CROs Form New Industry Standards Group to Improve Collaboration with Sponsors	18-03-27	BU
Veeva : Leading CROs Form New Industry Standards Group to Improve Collaboration With Sponsors	18-03-27	BU
Medidata : inVentiv Health Selects Medidata Enroll®, Medidata's eConsent Platform, to Accelerate Clinical Trials	17-06-26	PU
Medidata : inVentiv Health Selects Medidata Enroll®, Medidata’s eConsent Platform, to Accelerate Clinical Trials	17-06-26	BU
Veeva : inVentiv Health Expedites Site Activation with Veeva Systems	16-10-18	BU
SI : Students From Indiana and Minnesota Named Region Three Siemens Competition Winners	15-11-16	BU
Healthcare Businesswomen's Association Honors Seven Top inVentiv Health Leaders For Their Visionary Healthcare Expertise	15-05-14	PR
Veeva Systems : Vault Selected by inVentiv Health Clinical to Empower Sponsors with Cloud-based eTMF Clinical Trial Platform	14-10-21	BU
PURE Bioscience, Inc. announced that it has received $1.20 million in funding from C.M.S. Capital, LLC, Gemini Investment Strategies, LLC, JMJ Financial Group Inc., Stahler Investments LLC, and Tripod Group, LLC.	12-07-09	CI
PURE Bioscience, Inc. announced that it expects to receive $1.33 million in funding from C.M.S. Capital, LLC, Gemini Investment Strategies, LLC, JMJ Financial Group Inc., Stahler Investments LLC, and Tripod Group, LLC.	12-06-26	CI

No results for this search